Amlodipine/hydrochlorothiazide/losartan

氨氯地平/氢氯噻嗪/氯沙坦

Report date: 2024/01/17 20:00:38

Base Information

Drug NameAmlodipine/hydrochlorothiazide/losartan
Drug Alias Name氯沙坦钾/氨氯地平/氢氯噻嗪losartan/amlodipine/hydrochlorothiazidehydrochlorothiazide/amlodipine /losartan苯磺酸氨氯地平/氯沙坦钾/氢氯噻嗪氨氯地平/氯沙坦钾/氢氯噻嗪 +[12] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsThiazide-sensitive sodium-chloride cotransporterAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes HydrochlorothiazideLosartan PotassiumAmlodipine Besylate
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaPending
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme LLCBeijing Hanmi Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A